What does Coris Bioconcept do?
CORIS BIOCONCEPT specializes in the development and production of diagnostic tests for infectious diseases. The company focuses on providing high-quality, rapid diagnostic solutions to healthcare professionals. Its product range includes antigen and antibody tests for various pathogens, enhancing disease detection and management.
- Sectors
- Wholesalers
- Signals
-
Reporting lossesReporting losses € -392K
The company reported a loss in the latest financial year.
Strong equityStrong equity € 5.02MStrong equity provides a buffer against setbacks.
Low riskLow risk 82.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.85A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 180KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 179KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 5.45MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 13.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2026
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Turnover
|
€
5.45M
|
|
|
|
|
€
3.06M
|
€
2.44M
|
€
1.83M
|
€
2.82M
|
|
|
€
179K
|
€
322K
|
€
-61K
|
€
800K
|
|
|
€
-392K
|
€
-471K
|
€
-853K
|
€
-27K
|
|
|
€
5.02M
|
€
5.43M
|
€
5.92M
|
€
6.96M
|
|
|
82.14%
|
78.64%
|
77.67%
|
80.15%
|
|
|
€
1.09M
|
€
1.47M
|
€
1.70M
|
€
1.72M
|
|
|
€
1.52M
|
€
1.62M
|
€
2.74M
|
€
3.71M
|
|
|
32.30
|
31.50
|
24.60
|
|
Publications 33
All publications- Demissions, Nominations 17/12/2024
- Demissions, Nominations 30/09/2024
- Demissions, Nominations 19/06/2024
- Demissions, Nominations 28/08/2023
- Demissions, Nominations 09/08/2023
Frequently asked questions
Answers to the most common questions about Coris Bioconcept, based on official government data and the filed annual accounts.
What is the VAT number of Coris Bioconcept?
The VAT number of Coris Bioconcept is BE0459.020.430.
How many employees work at Coris Bioconcept?
In 2026, Coris Bioconcept employed 32.30 full-time equivalents (FTE).
When was Coris Bioconcept established?
Coris Bioconcept was founded in 16-10-1996.
What is the official address of Coris Bioconcept?
The official address of Coris Bioconcept is Rue Guillaume Fouquet,Isnes 11 Gembloux 5032.
What is the legal form of Coris Bioconcept?
The juridical form of Coris Bioconcept is Private limited company (BV/SRL).
What is the annual revenue of Coris Bioconcept?
The revenue of Coris Bioconcept for the 2026 financial year was €5,452,741.
What does Coris Bioconcept do?
CORIS BIOCONCEPT specializes in the development and production of diagnostic tests for infectious diseases. The company focuses on providing high-quality, rapid diagnostic solutions to healthcare professionals. Its product range includes antigen and antibody tests for various pathogens, enhancing disease detection and management.
Is Coris Bioconcept a reliable company?
Coris Bioconcept is a registered Rechtspersoon with company number 0459.020.430 and can be verified through the official CBE database.
What is the credit limit of Coris Bioconcept?
The estimated credit limit of Coris Bioconcept is €698,540.
Is Coris Bioconcept still active?
Coris Bioconcept currently has the status "Normal situation" and is active.